Dose-Response Association of Uncontrolled Blood Pressure and Cardiovascular Disease Risk Factors with Hyperuricemia and Gout

被引:46
|
作者
Juraschek, Stephen P. [1 ,2 ]
Kovell, Lara C. [3 ]
Miller, Edgar R. [1 ,2 ,3 ]
Gelber, Allan C. [1 ,2 ,3 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
美国国家卫生研究院;
关键词
SERUM URIC-ACID; ATHEROSCLEROSIS RISK; INCIDENT HYPERTENSION; METABOLIC SYNDROME; NATIONAL-HEALTH; POPULATION; PREVALENCE; EPIDEMIOLOGY; PATHOGENESIS; CRITERIA;
D O I
10.1371/journal.pone.0056546
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: First-line therapy of hypertension includes diuretics, known to exert a multiplicative increase on the risk of gout. Detailed insight into the underlying prevalence of hyperuricemia and gout in persons with uncontrolled blood pressure (BP) and common comorbidities is informative to practitioners initiating antihypertensive agents. We quantify the prevalence of hyperuricemia and gout in persons with uncontrolled BP and additional cardiovascular disease (CVD) risk factors. Methods and Findings: We performed a cross-sectional study of non-institutionalized US adults, 18 years and older, using the National Health and Nutrition Examination Surveys in 1988-1994 and 1999-2010. Hyperuricemia was defined as serum uric acid >6.0 mg/dL in women; >7.0 mg/dL in men. Gout was ascertained by self-report of physician-diagnosed gout. Uncontrolled BP was based on measured systolic BP >= 140 mmHg and diastolic BP >= 90 mmHg. Additional CVD risk factors included obesity, reduced glomerular filtration rate, and dyslipidemia. The prevalence of hyperuricemia was 6-8% among healthy US adults, 10-15% among adults with uncontrolled BP, 22-25% with uncontrolled BP and one additional CVD risk factor, and 34-37% with uncontrolled BP and two additional CVD risk factors. Similarly, the prevalence of gout was successively greater, at 1-2%, 4-5%, 6-8%, and 8-12%, respectively, across these same health status categories. In 2007-2010, those with uncontrolled BP and 2 additional CVD risk factors compared to those without CVD risk factors had prevalence ratios of 4.5 (95% CI 3.5-5.6) and 4.5 (95% CI: 3.1-6.3) for hyperuricemia and gout respectively (P < 0.01). Conclusions: Health care providers should be cognizant of the incrementally higher prevalence of hyperuricemia and gout among patients with uncontrolled BP and additional CVD risk factors. With one in three people affected by hyperuricemia among those with several CVD risk factors, physicians should consider their anti-hypertensive regimens carefully and potentially screen for hyperuricemia or gout.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] DOSE-RESPONSE STUDY OF METFORMIN AND CARDIOVASCULAR RISK-FACTORS IN TYPE-2 DIABETES
    GRANT, PJ
    DIABETOLOGIA, 1994, 37 : A200 - A200
  • [42] Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women
    Nanchahal, K
    Ashton, WD
    Wood, DA
    JOURNAL OF HYPERTENSION, 2000, 18 (07) : 833 - 841
  • [43] Association of physical inactivity with blood pressure and cardiovascular risk factors in Amerindian schoolchildren
    Alvarez, Cristian
    Ramirez-Campillo, Rodrigo
    Saez-Lafourcade, Roberto
    Delgado-Floody, Pedro
    Martinez-Salazar, Cristian
    Celis-Morales, Carlos
    Ramirez-Velez, Robinson
    Alonso-Martinez, Alicia
    Izquierdo, Mikel
    AMERICAN JOURNAL OF HUMAN BIOLOGY, 2019, 31 (05)
  • [44] Determinants of uncontrolled blood pressure and lipids in patients with established cardiovascular disease
    Brotons, C.
    Moral, I.
    Rayo, E.
    Martinez, M.
    Soriano, N.
    EUROPEAN HEART JOURNAL, 2006, 27 : 302 - 303
  • [45] PROPRANOLOL IN THE CONTROL OF BLOOD-PRESSURE - A DOSE-RESPONSE STUDY
    SERLIN, MJ
    ORME, MLE
    BABER, NS
    SIBEON, RG
    LAWS, E
    BRECKENRIDGE, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) : 586 - 592
  • [46] Zinc supplementation and cardiovascular disease risk factors: A GRADE-assessed systematic review and dose-response meta-analysis
    Nazari, Matin
    Ashtary-Larky, Damoon
    Nikbaf-Shandiz, Mahlagha
    Goudarzi, Kian
    Bagheri, Reza
    Dolatshahi, Sina
    Omran, Hossein Salehi
    Amirani, Niusha
    Ghanavati, Matin
    Asbaghi, Omid
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2023, 79
  • [47] Birth Weight and Risk of Cardiovascular Disease Incidence in Adulthood: a Dose-Response Meta-analysis
    Reza Mohseni
    Shimels Hussien Mohammed
    Maryam Safabakhsh
    Fatemeh Mohseni
    Zahra Sajedi Monfared
    Javad Seyyedi
    Zahra Noorani Mejareh
    Shahab Alizadeh
    Current Atherosclerosis Reports, 2020, 22
  • [48] Dose-response association between cardiovascular health and mortality in cancer survivors
    Lopez-Bueno, Ruben
    Yang, Lin
    Calatayud, Joaquin
    Andersen, Lars Louis
    Cruz, Borja del Pozo
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (01)
  • [49] Parity and risk of maternal cardiovascular disease: A dose-response meta-analysis of cohort studies
    Li, Wenzhen
    Ruan, Wenyu
    Lu, Zuxun
    Wang, Dongming
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 26 (06) : 592 - 602
  • [50] Birth Weight and Risk of Cardiovascular Disease Incidence in Adulthood: a Dose-Response Meta-analysis
    Mohseni, Reza
    Mohammed, Shimels Hussien
    Safabakhsh, Maryam
    Mohseni, Fatemeh
    Monfared, Zahra Sajedi
    Seyyedi, Javad
    Mejareh, Zahra Noorani
    Alizadeh, Shahab
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (03)